CN106266195A - Medicine for treating suppurative dactylitis by oral administration and external use - Google Patents
Medicine for treating suppurative dactylitis by oral administration and external use Download PDFInfo
- Publication number
- CN106266195A CN106266195A CN201610816010.1A CN201610816010A CN106266195A CN 106266195 A CN106266195 A CN 106266195A CN 201610816010 A CN201610816010 A CN 201610816010A CN 106266195 A CN106266195 A CN 106266195A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- oral administration
- dactylitis
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 229940079593 drug Drugs 0.000 title abstract description 7
- 206010064769 Dactylitis Diseases 0.000 title abstract description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 7
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 claims abstract description 7
- 229960001625 furazolidone Drugs 0.000 claims abstract description 7
- 239000011593 sulfur Substances 0.000 claims abstract description 6
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 6
- 206010034016 Paronychia Diseases 0.000 claims description 18
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 5
- 229940025250 camphora Drugs 0.000 claims description 5
- 239000010238 camphora Substances 0.000 claims description 5
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000723346 Cinnamomum camphora Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 229960000846 camphor Drugs 0.000 abstract 1
- 229930008380 camphor Natural products 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000008961 swelling Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 208000033809 Suppuration Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 239000011505 plaster Substances 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241001597062 Channa argus Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000009191 jumping Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000361 pesticidal effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XVKPBYJWSA-N (1s,4r)-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound C1C[C@@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-XVKPBYJWSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000411545 Punargentus Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 201000006592 giardiasis Diseases 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000001581 lymphogranuloma venereum Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008533 pain sensitivity Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001604 vasa vasorum Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
An oral and external medicine for treating purulent dactylitis, which belongs to the technical field of medicines and aims to solve the treatment problem of the purulent dactylitis and is characterized by being prepared by combining the following traditional Chinese medicines in parts by mass: firstly, externally applied medicine: 1 part of furazolidone tablet, 1 part of alum, 1 part of sulfur and 1 part of camphor; secondly, taking the medicine orally: 15 parts of radix rehmanniae, 12 parts of honeysuckle, 12 parts of fructus forsythiae, 12 parts of spina gleditsiae, 12 parts of radix achyranthis bidentatae and 7 parts of liquorice.
Description
Technical field
The present invention relates to the composition of medicine of a kind of therapeutic felon, particularly to the treatment combined with plurality of Chinese
Medicine, belongs to pharmaceutical technology field.
Background technology
Whitlow is to occur at referring to the subcutaneous pyogenic infection of minor details.During because infecting, whole finger abdomen height swelling
Just as snakehead, therefore named " snakehead furuncle " or " scrofula cellulitis ", because referring to that Pericarpium Arecae undertissue arranges very closely therefore in initial infection, is organized the most very
Swelling, intracavity tension force substantially increases simultaneously, sharp ache, and the blood supply of phalangette is hindered.Disease local symptom in early days is relatively
Weight；Abscess is difficult to the fluctuation of detection infected area after being formed, be the key character of this disease.
Whitlow pathogenesis: the skin of digital tip facies palmaris is intermembranous with phalanx bone many vertical shape fiber ropes,
Soft tissue is divided into many airtight loculuses, containing fatty tissue and abundant teleneuron net in chamber.When occurring to infect, pus
It is difficult to spread to surrounding, therefore swelling is the most notable.But pus cavity pressure is the highest, it is possible not only to cause the most violent pain, also
The vasa vasorum of phalangette can be oppressed, cause phalanges ischemia, downright bad healthy search.Additionally, pus is directly invaded and phalanges, also can
Cause osteomyelitis.
Whitlow clinical manifestation: at the beginning of morbidity, finger mild swelling, rubescent, twinge.Then finger swelling increases the weight of,
Skin tension substantially becomes big, and patient often feels violent jumping pain, it is difficult to sleeping.And have the symptom such as fever with aversion to cold, general malaise.Abscess
Phase, thrombosis in blood capillary, local organization tends to downright bad, whole finger abdomen can height swelling, just as snakehead.Abscess is formed
After, finger pain alleviates on the contrary, and color of the leather is white by red turn, but difficulty finds fluctuation.Skin ulceration pyorrhea, gradually heals.
The treatment of whitlow.Can give hot compress in early days, potassium permanganate soaks, 3% iodine tincture is embrocated, positive infection
Treatment can make inflammatory resolution.Before abscess is formed, available ruyi jinhuang powder, ruyi jinhuang san trouble of applying ointment or plaster refers to, but should incision and drainage as early as possible, because of infected area
It is difficult to find fluctuation, therefore according to the time infected, the incision and drainage at once when jumping pain occurs or impact is slept, it is impossible to wait.
Even if not having many puss after Qie Kaiing, to relief of symptoms, controlling inflammation, to develop in depth also be useful.Referring to nerve block fiber crops
Under liquor-saturated, referring to that stringer otch is made in side in minor details, otch far-end is less than nail groove 1/2, and near-end, less than referring to joint band, leads to for drain
Freely change dressings facility, a fusiformis leather strap can be excised in incision.Art is removed slough, thoroughly opens the fiber occurring to infect
Every, but the complete of deep layer periosteum and sheath pipe should be protected, in order to avoid inflammation diffusion.Insert photoplate drain.Art should be avoided row both sides
Aboral drainage, does not more make the lymphogranuloma inguinale shape drain otch of finger tip.The former often leaves bigger cicatrix under referring to abdomen, makes to hold thing, pinch thing
Time pain sensitivity, affect function.The latter's Ze Yin cicatrix retraction makes finger tip health search injustice, affects function and profile.Operation is
The method of relief of symptoms.
Western medicine mainly uses antibiotic therapy, and first-selected penicillin medicine intramuscular injection, allergy sufferers preferably uses cephalosporins.
Often make antibiotic can cause people's hypoimmunity.
Summary of the invention
Owing to dactylitis occurs in fingernail affected part, there is space with the junction of the human body in fingernail, these spaces become finger
Corner or spot as yet untouched by a clean-up campaign, it is easy to breed bacteria, virus cause inflammation, suppuration.Chinese medicine is thought: whitlow belongs to diseases caused by exogenous pathogenic factor
Heresy poison, the rotten bone of erosion wound, pyretic toxicity pent up, and treatment should be drawn out pus by applying a plaster to the affected part with Pesticidal and sterilizing, heat clearing away, the cooperation of the medicine oral administration and externally of dissipating blood stasis of subsiding a swelling is controlled
Treat.
According to medical analysis above, the medicine of the therapeutic felon of oral administration and externally solve the scheme that problem taked be by
The most each Chinese medicine quality part ratio combines: one, external used medicine: Furazolidone tablet 1 part, Alumen 1 part, sulfur 1 part, Camphora 1 part；
Two, endo-medicine: 15 parts of the Radix Rehmanniae, Flos Lonicerae 12 parts, Fructus Forsythiae 12 parts, Spina Gleditsiae 12 parts, Radix Achyranthis Bidentatae 12 parts, 7 parts of Radix Glycyrrhizae.
Each property of medicine effect forming Chinese medicine in the medicine of the lower therapeutic felon of surface analysis oral administration and externally.Furazolidone
Sheet is in western liquid, medicine, yellow powder mixing starch compressed tablets, has antibacterial, effect of parasite killing, and the property of medicine relatively relaxes, and is applied to wound
Mouth can be dissolved in blood or the transudate of wound in time, wound is not had zest, is mainly used in the antibacterial caused by sensitive organism
Property dysentery, enteritis, cholera, it is also possible to for typhoid fever, paratyphoid fever, giardiasis, trichomoniasis etc..Alumen sour-puckery flavor cold in nature,
Having stronger astriction, the traditional Chinese medical science is thought, has removing toxic substances parasite killing, quick-fried wet antipruritic, antidiarrheal of stopping blooding, effect of heat clearing away expectorant.In
Effect of medicine sulfur: external counteracting toxic substances, parasite killing, removing dampness, antipruritic；Three effects below have certain effect, counteracting toxic substances for sulfur
To sore, carbuncle and painful swelling, how alone compound recipe is embrocates all effectively, but effect is the strongest.Effect of Chinese medicine Camphora: sensible refreshment, wards off dirty promoting the circulation of QI,
Reducing swelling and alleviating pain, killing parasites for relieving itching.Natural camphor ball is usually the organic compound having fragranced extracted from Lignum cinnamomi camphorae branch and leaf, can
As a kind of moth-proof and mould-proof product, toxicity is relatively small.Radix Rehmanniae clearing away heat and promoting production of body fluid, removing heat from blood, hemostasis.The Radix Rehmanniae is used for consumption of YIN caused by febrile disease, crimson tongue
Excessive thirst, sends out speckle dermexanthesis, spits blood, epistaxis, laryngopharynx swelling and pain.Flos Lonicerae can dispelling wind-heat, be also apt to removing summer-heat blood poison, for various hot
Disease, such as fever of the body, dermexanthesis, sends out the cards such as speckle, pyretic toxicity carbuncle sore, laryngopharynx swelling and pain, and equal effect is notable.Effect of Fructus Forsythiae and effect: heat clearing away solution
Poison；Dispersing swelling and dissipating binds anemopyretic cold；Main anemopyretic cold；Epidemic febrile disease；Pyretic stranguria urine retention；Carbuncle；Toxic swelling；Scrofula；Goiter；Sore throat.Spina Gleditsiae
Being the Spina jujubae of a kind of plant Fructus Gleditsia, be a herb, be considered pungent by the traditional Chinese medical science, Wen De, main effect is to draw out pus by applying a plaster to the affected part to dispel the wind, detumescence
Evacuation of pus, is mainly used on the dermatosis of health.Radix Achyranthis Bidentatae energy nourishing and protecting liver, foster kidney the kidney invigorating, blood-supplementing blood-nourishing, invigorating vital QI, tune
Reason the intestines and stomach, memory reinforcing, YIN nourishing nourishing YIN, appetite-stimulating indigestion-relieving, elimination edema, raising metabolism, defying age.Radix Glycyrrhizae property is put down, and sweet in the mouth has
Detoxify, eliminate the phlegm, pain relieving, spasmolytic is so that the pharmacological action such as anticancer；In the traditional Chinese medical science, Radix Glycyrrhizae invigorating the spleen and replenishing QI, grow and cough lung moistening, emergency solution
Poison, is in harmonious proportion hundred medicines；Radix Glycyrrhizae also has antiinflammatory, antiviral, protecting liver and detoxication and strengthens immune effect.
The medicine of the therapeutic felon of oral administration and externally provides the benefit that: the therapeutic felon of oral administration and externally
Medicine belongs to diseases caused by exogenous pathogenic factor heresy poison by analysis whitlow, rotten bone is hindered in erosion, pyretic toxicity pents up, and takes the medicine with Pesticidal and sterilizing
External；Draw out pus by applying a plaster to the affected part with heat clearing away, the medicine of dissipating blood stasis of subsiding a swelling takes orally and coordinates as medicine, and theory of medicine is correct, and therapeutic effect is obvious.
Detailed description of the invention
The medicine of the therapeutic felon of oral administration and externally is further illustrated below with embodiment.
The medicine of the therapeutic felon of oral administration and externally is suitable for the agent that a whitlow patient uses
Amount medication amount be to combine by following each drug quality: one, external used medicine: Furazolidone tablet 1, Alumen 1 gram, sulfur 1 gram,
Camphora 1 gram；Two, endo-medicine: 15 grams of the Radix Rehmanniae, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Spina Gleditsiae 12 grams, Radix Achyranthis Bidentatae 12 grams, 7 grams of Radix Glycyrrhizae.
Using method: by 1 crushed into powder of external used medicine furazolidone, by 1 gram of crushed into powder of Camphora, then by furazolidone
Powder, camphor powder, sofril, Alumen powder mix homogeneously become mixed powder, and mixed powder is applied to suppurative finger affected part；With
Time, by 15 grams of the Chinese medicine for oral administration Radix Rehmanniae, Flos Lonicerae 12 grams, Fructus Forsythiae 12 grams, Spina Gleditsiae 12 grams, Radix Achyranthis Bidentatae 12 grams, 7 grams of Radix Glycyrrhizae mixing with
More than 30 minutes water intaking decocting liquids of 1.5 liters of soak by water are taken.
The medicine of the therapeutic felon of oral administration and externally uses checking, effectively through 20 many cases whitlow patients
Rate 100%, cure rate 100%.The human body that medicine of the present invention is equally applicable to some bacillary infringements and traumatic injury causes other
Suppurative or the nonsuppurative inflammation at position, curative effect is the most notable.
Claims (1)
1. the medicine of the therapeutic felon of oral administration and externally, is characterized in that combining by following each Chinese medicine quality part ratio: one,
External used medicine: Furazolidone tablet 1 part, Alumen 1 part, sulfur 1 part, Camphora 1 part；Two, endo-medicine: 15 parts of the Radix Rehmanniae, Flos Lonicerae 12
Part, Fructus Forsythiae 12 parts, Spina Gleditsiae 12 parts, Radix Achyranthis Bidentatae 12 parts, 7 parts of Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610816010.1A CN106266195A (en) | 2016-09-12 | 2016-09-12 | Medicine for treating suppurative dactylitis by oral administration and external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610816010.1A CN106266195A (en) | 2016-09-12 | 2016-09-12 | Medicine for treating suppurative dactylitis by oral administration and external use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106266195A true CN106266195A (en) | 2017-01-04 |
Family
ID=57711000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610816010.1A Withdrawn CN106266195A (en) | 2016-09-12 | 2016-09-12 | Medicine for treating suppurative dactylitis by oral administration and external use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106266195A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104623112A (en) * | 2013-11-08 | 2015-05-20 | 陈洪波 | Plaster for treating snake-head furuncle |
-
2016
- 2016-09-12 CN CN201610816010.1A patent/CN106266195A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104623112A (en) * | 2013-11-08 | 2015-05-20 | 陈洪波 | Plaster for treating snake-head furuncle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102139030B (en) | Oral Chinese herbal preparation for treating gingivitis and preparation method thereof | |
| CN101791378B (en) | Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration | |
| CN104324125A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN105902660A (en) | Pharmaceutical composition for treating bedsores, diabetic feet and eczema | |
| CN104721665A (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN106266195A (en) | Medicine for treating suppurative dactylitis by oral administration and external use | |
| CN1322871C (en) | Preparation of compound pseudo-ginseng drop pellets for treating traumatologic disease | |
| CN101983650A (en) | Medicament for treating dermatitis aestivale | |
| CN101066425A (en) | Chinese medicine prepn for treating ungual mycosis | |
| CN102872210B (en) | Traditional Chinese medicine for treating urticaria | |
| CN104353043A (en) | Traditional Chinese medicine composition for treating dawn diarrhea and preparation method thereof | |
| CN104306707A (en) | Medicament composition for treating bedsore | |
| CN110384785A (en) | A kind of external application Chinese medicine medical fluid and preparation method thereof for treating virus flu | |
| CN110585379A (en) | External application medicine for treating dermatitis | |
| CN110403995B (en) | Traditional Chinese medicine composition for treating superficial phlebitis and preparation, use methods and application thereof | |
| CN107744549A (en) | A kind of medicine for treating toothache and preparation method thereof | |
| CN107412524A (en) | Treat the medicine of decayed tooth | |
| CN104971209A (en) | Externally used agent for treating tinea pedis and preparation method thereof | |
| CN106344837A (en) | Traditional Chinese medicine composition for treating dermatophytosis | |
| CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
| CN101632762A (en) | Traditional Chinese medicine ointment for treating child aphtha | |
| CN102266408A (en) | Chinese medicine preparation for intervening in cutaneous prutitus and preparation method thereof | |
| CN104435232B (en) | A kind of Chinese medicine composition for treating toothache | |
| CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof | |
| CN104906352A (en) | Traditional Chinese medicine liquid for treating deficiency-fire flaring-up type infantile oral ulcer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170104 |
|
| WW01 | Invention patent application withdrawn after publication |